Sabra Healthcare REIT (NASDAQ:SBRA – Get Free Report) was downgraded by investment analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a report issued on Saturday.
SBRA has been the subject of a number of other reports. Weiss Ratings reiterated a “buy (b)” rating on shares of Sabra Healthcare REIT in a report on Wednesday, October 8th. Wells Fargo & Company reduced their price target on shares of Sabra Healthcare REIT from $21.00 to $20.00 and set an “overweight” rating for the company in a research report on Tuesday, October 21st. Truist Financial lifted their price objective on shares of Sabra Healthcare REIT from $18.00 to $20.00 and gave the stock a “hold” rating in a research report on Tuesday, September 2nd. National Bankshares set a $22.00 price target on shares of Sabra Healthcare REIT in a report on Friday, October 17th. Finally, JMP Securities boosted their target price on Sabra Healthcare REIT from $20.00 to $22.00 and gave the company a “market outperform” rating in a research note on Wednesday, August 6th. One analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $20.75.
View Our Latest Research Report on SBRA
Sabra Healthcare REIT Stock Performance
Sabra Healthcare REIT (NASDAQ:SBRA – Get Free Report) last posted its quarterly earnings results on Wednesday, November 5th. The real estate investment trust reported $0.38 earnings per share for the quarter, beating the consensus estimate of $0.37 by $0.01. The firm had revenue of $190.04 million during the quarter, compared to the consensus estimate of $193.44 million. Sabra Healthcare REIT had a net margin of 24.87% and a return on equity of 6.69%. The business’s revenue was up 6.7% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.37 earnings per share. Sabra Healthcare REIT has set its FY 2025 guidance at 1.455-1.465 EPS. On average, equities analysts forecast that Sabra Healthcare REIT will post 1.45 earnings per share for the current year.
Institutional Inflows and Outflows
Institutional investors have recently made changes to their positions in the company. Oppenheimer & Co. Inc. boosted its stake in Sabra Healthcare REIT by 1.7% during the third quarter. Oppenheimer & Co. Inc. now owns 33,984 shares of the real estate investment trust’s stock valued at $633,000 after buying an additional 581 shares during the period. Louisiana State Employees Retirement System grew its holdings in shares of Sabra Healthcare REIT by 0.9% during the first quarter. Louisiana State Employees Retirement System now owns 66,300 shares of the real estate investment trust’s stock worth $1,158,000 after purchasing an additional 600 shares in the last quarter. State of Michigan Retirement System increased its position in shares of Sabra Healthcare REIT by 1.1% in the first quarter. State of Michigan Retirement System now owns 56,649 shares of the real estate investment trust’s stock worth $990,000 after purchasing an additional 600 shares during the last quarter. Amalgamated Bank increased its position in shares of Sabra Healthcare REIT by 0.6% in the third quarter. Amalgamated Bank now owns 105,159 shares of the real estate investment trust’s stock worth $1,960,000 after purchasing an additional 612 shares during the last quarter. Finally, Diversify Advisory Services LLC raised its stake in Sabra Healthcare REIT by 5.7% in the first quarter. Diversify Advisory Services LLC now owns 12,878 shares of the real estate investment trust’s stock valued at $226,000 after purchasing an additional 689 shares in the last quarter. Institutional investors own 99.40% of the company’s stock.
About Sabra Healthcare REIT
Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.
Featured Stories
- Five stocks we like better than Sabra Healthcare REIT
- About the Markup Calculator
- OpenAI’s Restructuring Sets up What Could Be the Biggest IPO Ever
- Manufacturing Stocks Investing
- 2 Rare Earth Stocks the U.S. Government Doesn’t Want to Fail
- What is a support level?
- CrowdStrike Partners With CoreWeave But Investors Sell the News
Receive News & Ratings for Sabra Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.
